DE3470744D1 - New camptothecin derivatives and process for preparing same - Google Patents
New camptothecin derivatives and process for preparing sameInfo
- Publication number
- DE3470744D1 DE3470744D1 DE8484108257T DE3470744T DE3470744D1 DE 3470744 D1 DE3470744 D1 DE 3470744D1 DE 8484108257 T DE8484108257 T DE 8484108257T DE 3470744 T DE3470744 T DE 3470744T DE 3470744 D1 DE3470744 D1 DE 3470744D1
- Authority
- DE
- Germany
- Prior art keywords
- substituted
- ring
- group
- atom
- camptothecin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58126946A JPS6019790A (ja) | 1983-07-14 | 1983-07-14 | 新規なカンプトテシン誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3470744D1 true DE3470744D1 (en) | 1988-06-01 |
Family
ID=14947803
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8484108257T Expired DE3470744D1 (en) | 1983-07-14 | 1984-07-13 | New camptothecin derivatives and process for preparing same |
DE198484108257T Pending DE137145T1 (de) | 1983-07-14 | 1984-07-13 | Camptothecin-derivate und verfahren zu deren herstellung. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE198484108257T Pending DE137145T1 (de) | 1983-07-14 | 1984-07-13 | Camptothecin-derivate und verfahren zu deren herstellung. |
Country Status (8)
Country | Link |
---|---|
US (1) | US4604463A (de) |
EP (1) | EP0137145B1 (de) |
JP (1) | JPS6019790A (de) |
AT (1) | ATE33839T1 (de) |
CA (1) | CA1235415A (de) |
DE (2) | DE3470744D1 (de) |
LU (1) | LU90074I2 (de) |
NL (1) | NL980026I2 (de) |
Families Citing this family (170)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4981968A (en) * | 1987-03-31 | 1991-01-01 | Research Triangle Institute | Synthesis of camptothecin and analogs thereof |
US5244903A (en) * | 1987-03-31 | 1993-09-14 | Research Triangle Institute | Camptothecin analogs as potent inhibitors of topoisomerase I |
US5106742A (en) * | 1987-03-31 | 1992-04-21 | Wall Monroe E | Camptothecin analogs as potent inhibitors of topoisomerase I |
US5227380A (en) * | 1987-03-31 | 1993-07-13 | Research Triangle Institute | Pharmaceutical compositions and methods employing camptothecins |
US4894456A (en) * | 1987-03-31 | 1990-01-16 | Research Triangle Institute | Synthesis of camptothecin and analogs thereof |
US5122526A (en) * | 1987-03-31 | 1992-06-16 | Research Triangle Institute | Camptothecin and analogs thereof and pharmaceutical compositions and method using them |
US5053512A (en) * | 1987-04-14 | 1991-10-01 | Research Triangle Institute | Total synthesis of 20(S) and 20(R)-camptothecin and compthothecin derivatives |
US5364858A (en) * | 1987-03-31 | 1994-11-15 | Research Triangle Institute | Camptothecin analogs as potent inhibitors of topoisomerase I |
US5049668A (en) * | 1989-09-15 | 1991-09-17 | Research Triangle Institute | 10,11-methylenedioxy-20(RS)-camptothecin analogs |
US5180722A (en) * | 1987-04-14 | 1993-01-19 | Research Triangle Institute | 10,11-methylenedioxy-20(RS)-camptothecin and 10,11-methylenedioxy-20(S)-camptothecin analogs |
US5340817A (en) * | 1987-04-14 | 1994-08-23 | Research Triangle Institute | Method of treating tumors with anti-tumor effective camptothecin compounds |
US5122606A (en) * | 1987-04-14 | 1992-06-16 | Research Triangle Institute | 10,11-methylenedioxy camptothecins |
US4939255A (en) * | 1987-06-24 | 1990-07-03 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic camptothecin derivatives |
US4943579A (en) * | 1987-10-06 | 1990-07-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Water soluble prodrugs of camptothecin |
US5004758A (en) * | 1987-12-01 | 1991-04-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells |
JPH0615547B2 (ja) * | 1988-01-20 | 1994-03-02 | 株式会社ヤクルト本社 | 新規なカンプトテシン誘導体 |
US5225404A (en) * | 1989-11-06 | 1993-07-06 | New York University | Methods of treating colon tumors with tumor-inhibiting camptothecin compounds |
US5552154A (en) | 1989-11-06 | 1996-09-03 | The Stehlin Foundation For Cancer Research | Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof |
US5658920A (en) * | 1991-01-16 | 1997-08-19 | Daiichi Pharmaceutical Co., Ltd. | Substituted 1H,12H-benz-[DE]pyrano[3',4':6,7] indolizino[1,2-B]quinoline-10,13(9H,15H)-dione compound |
US6407115B1 (en) * | 1991-01-16 | 2002-06-18 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic compound |
EP0612248B1 (de) | 1991-11-15 | 2003-08-20 | Smithkline Beecham Corporation | Cisplatin und Topotecan enthaltende Zusammensetzung als antitumor. |
US6080751A (en) * | 1992-01-14 | 2000-06-27 | The Stehlin Foundation For Cancer Research | Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof |
US5391745A (en) * | 1992-07-23 | 1995-02-21 | Sloan-Kettering Institute For Cancer Research | Methods of preparation of camptothecin analogs |
US5446047A (en) * | 1992-07-23 | 1995-08-29 | Sloan-Kettering Institute For Cancer Research | Camptothecin analogues |
AP9300587A0 (en) * | 1992-11-12 | 1995-05-05 | Glaxo Inc | Water soluble camptothecin derivatives. |
US5447936A (en) * | 1993-12-22 | 1995-09-05 | Bionumerik Pharmaceuticals, Inc. | Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof |
GB9402934D0 (en) * | 1994-02-16 | 1994-04-06 | Erba Carlo Spa | Camptothecin derivatives and process for their preparation |
US5468754A (en) * | 1994-04-19 | 1995-11-21 | Bionumerik Pharmaceuticals, Inc. | 11,7 substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof |
US5604233A (en) * | 1994-04-28 | 1997-02-18 | Bionumerik Pharmaceuticals, Inc. | Lactone stable formulation of 7-ethyl camptothecin and methods for uses thereof |
US5597829A (en) * | 1994-05-09 | 1997-01-28 | Bionumerik Pharmaceuticals, Inc. | Lactone stable formulation of camptothecin and methods for uses thereof |
US5646159A (en) * | 1994-07-20 | 1997-07-08 | Research Triangle Institute | Water-soluble esters of camptothecin compounds |
US5614529A (en) * | 1994-09-22 | 1997-03-25 | Research Triangle Institute | Inhibition of plasmodia parasites by camptothecin compounds |
US5972955A (en) * | 1995-06-06 | 1999-10-26 | Dr. Reddy's Research Foundation | Water soluble C-ring analogues of 20(S)-camptothecin |
US6214836B1 (en) | 1995-06-06 | 2001-04-10 | Dr. Reddy's Research Foundation | Water soluble analogues of 20(S)-camptothecin |
US6177439B1 (en) | 1995-06-06 | 2001-01-23 | Reddy's Research Foundation | Water soluble analogues of 20(S)-camptothecin |
WO1996040886A1 (en) * | 1995-06-07 | 1996-12-19 | Thomas Jefferson University | Anti-fungal agents and methods of identifying and using the same |
WO1997019085A1 (en) * | 1995-11-22 | 1997-05-29 | Research Triangle Institute | Camptothecin compounds with combined topoisomerase i inhibition and dna alkylation properties |
US6395541B1 (en) | 1996-05-23 | 2002-05-28 | The Rockefeller University | Methods for the identification of compounds capable of inhibiting HIV-1 viral replication employing murine cell lines expressing human topoisomerase I |
JP4364305B2 (ja) * | 1996-08-19 | 2009-11-18 | バイオニューメリック ファーマシューティカルズ インク | 極めて脂肪親和性のカンプトテシン誘導体 |
CA2280855A1 (en) * | 1997-02-27 | 1998-09-03 | Pharmacia & Upjohn Company | Tamoxifen as a therapy to reduce irinotecan hydrochloride-induced diarrhea |
JP3046258B2 (ja) * | 1997-04-11 | 2000-05-29 | 株式会社ヤクルト本社 | 1−クロロカルボニル−4−ピペリジノピペリジンまたはその塩酸塩の製造方法 |
ID23424A (id) | 1997-05-14 | 2000-04-20 | Bayer Ag | Glikokonjugat dari 20(s)-kamptotesin |
US6214821B1 (en) | 1998-03-05 | 2001-04-10 | Washington State University Research Foundation | Methods and composition for the inhibition of cancer cells |
WO2000007605A1 (fr) * | 1998-08-05 | 2000-02-17 | Aventis Pharma S.A. | Utilisation de derives de la camptothecine, avec une toxicite gastro-intestinale reduite |
US6043367A (en) * | 1998-09-30 | 2000-03-28 | Roffler; Steve | Proactive antitumor compounds |
US20050281821A1 (en) * | 1999-01-06 | 2005-12-22 | Flavia Pernasetti | Method and composition for angiogenesis inhibition |
US6352996B1 (en) | 1999-08-03 | 2002-03-05 | The Stehlin Foundation For Cancer Research | Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
US6228855B1 (en) * | 1999-08-03 | 2001-05-08 | The Stehlin Foundation For Cancer Research | Aromatic esters of camptothecins and methods to treat cancers |
CA2385528C (en) | 1999-10-01 | 2013-12-10 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
US6159935A (en) * | 1999-11-29 | 2000-12-12 | Pharmacia & Upjohn Co. | Method for preventing diarrhea |
EE200200471A (et) | 2000-02-28 | 2003-12-15 | Aventis Pharma S.A. | Farmatseutiline kompositsioon, mis sisaldab kamptotetsiini või selle derivaati kombinatsioonis pürimidiini derivaadiga ning on ette nähtud vähktõve raviks |
US6545010B2 (en) | 2000-03-17 | 2003-04-08 | Aventis Pharma S.A. | Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer |
AR027687A1 (es) * | 2000-03-22 | 2003-04-09 | Yakult Honsha Kk | Procedimiento para preparar camptotecina |
DK1286671T3 (da) | 2000-05-15 | 2006-07-17 | Celgene Corp | Sammensætninger til behandling af colorektal cancer hvilke indeholder thalidomid og irinotecan |
AU6147401A (en) | 2000-05-15 | 2001-11-26 | Celgene Corp | Compositions and methods for the treatment of cancer |
US6486320B2 (en) | 2000-09-15 | 2002-11-26 | Aventis Pharma S.A. | Preparation of camptothecin and of its derivatives |
CN1200712C (zh) | 2000-10-27 | 2005-05-11 | 阿文蒂斯药物股份有限公司 | 用于治疗癌症的含喜树碱和1,2-二苯乙烯衍生物的组合物 |
US7390885B2 (en) * | 2001-11-26 | 2008-06-24 | Cell Matrix, Inc. | Humanized collagen antibodies and related methods |
US7365167B2 (en) * | 2001-11-26 | 2008-04-29 | Cell Matrix, Inc. | Humanized collagen antibodies and related methods |
EP2266590A3 (de) | 2002-02-22 | 2011-04-20 | Shire LLC | Wirkstoff-Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Wirkstoffen |
CN1649627A (zh) * | 2002-04-26 | 2005-08-03 | 法赫马西亚及普强有限公司 | 用于治疗、预防或延迟肿瘤发生的方法和组合物 |
US7217796B2 (en) | 2002-05-24 | 2007-05-15 | Schering Corporation | Neutralizing human anti-IGFR antibody |
CN100363366C (zh) * | 2002-06-27 | 2008-01-23 | 中国科学院上海药物研究所 | 一类喜树碱衍生物及制备方法 |
US8034831B2 (en) | 2002-11-06 | 2011-10-11 | Celgene Corporation | Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies |
US7563810B2 (en) | 2002-11-06 | 2009-07-21 | Celgene Corporation | Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases |
US20040186160A1 (en) * | 2002-12-13 | 2004-09-23 | Sugen, Inc. | Hexahydro-cyclohepta-pyrrole oxindole as potent kinase inhibitors |
US7151179B2 (en) | 2003-05-12 | 2006-12-19 | Scinopharm Taiwan, Ltd. | Process for the preparation of 7-alkyl-10-hydroxy-20(S)-camptothecin |
US7067666B2 (en) * | 2003-06-27 | 2006-06-27 | Research Triangle Institute | 7-substituted camptothecin and camptothecin analogs and methods for producing the same |
CZ299329B6 (cs) * | 2003-08-26 | 2008-06-18 | Pliva-Lachema A.S. | Zpusob výroby 7-ethyl-10-[ 4-(1-piperidino)-1-piperidino]karbonyloxykamptothecinu |
PE20050928A1 (es) * | 2003-11-21 | 2005-11-08 | Schering Corp | Combinaciones terapeuticas de anticuerpo anti-igfr1 |
CZ299593B6 (cs) * | 2003-12-16 | 2008-09-10 | Pliva-Lachema A. S. | Zpusob výroby 7-ethyl-10-hydroxykamptothecinu |
WO2005062985A2 (en) * | 2003-12-23 | 2005-07-14 | American Bioscience, Inc. | Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications |
US20080242691A1 (en) * | 2004-02-13 | 2008-10-02 | Kabushiki Kaisha Yakult Honsha | Aqueous Solution Preparation Containing Camptothecins |
MXPA06012145A (es) * | 2004-04-27 | 2007-01-31 | Wellstat Biologics Corp | Tratamiento del cancer utilizando virus y camptotecinas. |
DK1746976T3 (en) | 2004-05-03 | 2017-04-10 | Merrimack Pharmaceuticals Inc | LIPOSOMES SUITABLE FOR PHARMACEUTICAL SUPPLY |
US20050267141A1 (en) * | 2004-05-28 | 2005-12-01 | Phytogen Life Sciences Inc. | Process to prepare camptothecin derivatives |
MXPA06013874A (es) | 2004-06-01 | 2007-04-25 | Terumo Corp | Formulacion de irinotecan. |
US20050272757A1 (en) * | 2004-06-04 | 2005-12-08 | Phytogen Life Sciences Inc. | Process to prepare camptothecin derivatives and novel intermediate and compounds thereof |
WO2006027567A2 (en) | 2004-09-07 | 2006-03-16 | Biocompatibles Uk Limited | Drug delivery from embolic agents |
JP4829120B2 (ja) * | 2004-10-01 | 2011-12-07 | 株式会社ヤクルト本社 | イリノテカン酸付加塩 |
US7205385B2 (en) * | 2004-11-12 | 2007-04-17 | General Electric Company | Polymerization method for the synthesis of polypeptide imaging agents |
KR101345002B1 (ko) | 2005-01-21 | 2013-12-31 | 아스텍스 테라퓨틱스 리미티드 | 제약 화합물 |
WO2006082053A1 (en) * | 2005-02-02 | 2006-08-10 | Heidelberg Pharma Gmbh | 7-ethyl-10-hydroxy-camptothecin lipid ester derivatives |
CA2591081C (en) * | 2005-02-07 | 2014-10-28 | Fermion Oy | Process for the manufacturing of 7-ethyl-10-hydroxy camptothecin |
US7662964B2 (en) * | 2005-02-08 | 2010-02-16 | Fermion Oy | Process for producing [1,4′] bipiperidinyl-1′-carbonyl chloride or hydrochloride thereof |
US7767813B2 (en) | 2005-02-08 | 2010-08-03 | Fermion Oy | Preparation method |
WO2006096458A2 (en) * | 2005-03-04 | 2006-09-14 | Novacea, Inc. | Treatment of hyperproliferative diseases with anthraquinones |
US20070117784A1 (en) * | 2005-03-04 | 2007-05-24 | Novacea, Inc. | Treatment of hyperproliferative diseases with anthraquinones |
CN101222926B (zh) * | 2005-04-15 | 2013-07-17 | 默沙东公司 | 用于治疗或预防癌症的方法和组合物 |
CA2503099A1 (en) * | 2005-04-18 | 2006-10-18 | Kabushiki Kaisha Yakult Honsha | Pharmaceutical compositions containing camptothecins |
KR20080039344A (ko) * | 2005-07-14 | 2008-05-07 | 웰스테트 바이올로직스 코포레이션 | 바이러스, 플루오로피리미딘 및 캄토테신을 이용한 암치료방법 |
NZ587586A (en) * | 2005-07-18 | 2012-04-27 | Bipar Sciences Inc | Treatment of cancer |
TW200727900A (en) * | 2005-07-27 | 2007-08-01 | Yakult Honsha Kk | Aqueous solution preparation containing camptothecins |
ES2432553T3 (es) * | 2005-08-03 | 2013-12-04 | Avra Laboratories Pvt. Ltd. | Procedimiento de síntesis de intermedios clave para la producción de derivados de camptotecina |
JP4994618B2 (ja) * | 2005-08-11 | 2012-08-08 | 学校法人北里研究所 | Ts−1/カンプトテシン類による化学放射線療法 |
US20070048325A1 (en) * | 2005-08-24 | 2007-03-01 | Dennis Van Epps | Combination therapies for inhibiting integrin-extracellular matrix interactions |
AU2006292328B2 (en) | 2005-09-20 | 2012-12-20 | Scinopharm Singapore Pte, Ltd. | Novel crystal forms of irinotecan hydrochloride |
US7875602B2 (en) * | 2005-10-21 | 2011-01-25 | Sutter West Bay Hospitals | Camptothecin derivatives as chemoradiosensitizing agents |
EP1803725A1 (de) | 2005-12-13 | 2007-07-04 | W.C. Heraeus GmbH | Verfahren zur Herstellung von Irinotecan |
CN1982313B (zh) * | 2005-12-13 | 2010-12-01 | 深圳市天和医药科技开发有限公司 | 10位取代基上含多个有机羧酸基团的喜树碱化合物及其制法与组合物 |
US20070208050A1 (en) * | 2006-02-24 | 2007-09-06 | Palle Venkata Raghavendra Acha | Process for preparing irinotecan |
CN101033230B (zh) | 2006-03-10 | 2010-12-08 | 中国科学院上海药物研究所 | 一类喜树碱衍生物及其应用 |
CA2658015A1 (en) * | 2006-03-30 | 2007-10-11 | Diatos S.A. | Camptothecin-peptide conjugates and pharmaceutical compositions containing the same |
AR060635A1 (es) | 2006-04-27 | 2008-07-02 | Banyu Pharma Co Ltd | Derivados de 1,2-dihidro-3h-pirazolo[3,4-d]pirimidin-3-ona, composiciones farmaceuticas que los comprenden y su uso en el tratamiento del cancer |
JP2008081492A (ja) | 2006-08-31 | 2008-04-10 | Banyu Pharmaceut Co Ltd | オーロラa選択的阻害作用を有する新規アミノピリジン誘導体 |
US8143447B2 (en) | 2006-09-05 | 2012-03-27 | Bipar Sciences, Inc. | Treatment of cancer |
CN101534836B (zh) | 2006-09-05 | 2011-09-28 | 彼帕科学公司 | Parp抑制剂在制备治疗肥胖症的药物中的用途 |
CA2699184A1 (en) * | 2006-09-22 | 2008-03-27 | Labopharm Inc. | Compositions and methods for ph targeted drug delivery |
KR20090094804A (ko) * | 2006-10-06 | 2009-09-08 | 다케다 야쿠힌 고교 가부시키가이샤 | 조합 약물 |
EP2073807A1 (de) | 2006-10-12 | 2009-07-01 | Astex Therapeutics Limited | Pharmazeutische kombinationen |
US8916552B2 (en) | 2006-10-12 | 2014-12-23 | Astex Therapeutics Limited | Pharmaceutical combinations |
US7977336B2 (en) | 2006-12-28 | 2011-07-12 | Banyu Pharmaceutical Co. Ltd | Aminopyrimidine derivatives as PLK1 inhibitors |
US20090062323A1 (en) * | 2007-08-29 | 2009-03-05 | Protia, Llc | Deuterium-enriched irinotecan |
JP2011500684A (ja) * | 2007-10-19 | 2011-01-06 | バイパー サイエンシズ,インコーポレイティド | ベンゾピロン系parp阻害剤を用いる癌の処置方法および組成物 |
AU2008315048A1 (en) | 2007-10-23 | 2009-04-30 | Msd K.K. | Pyridone-substituted-dihydropyrazolopyrimidinone derivative |
NZ586125A (en) | 2007-11-12 | 2012-12-21 | Bipar Sciences Inc | Treatment of breast cancer with a parp inhibitor alone or in combination with anti-tumor agents |
AU2009231804B2 (en) * | 2008-03-31 | 2015-06-04 | Boston Medical Center Corporation | Predictive marker for topoisomerase I inhibitors |
US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
CN101397301A (zh) * | 2008-09-10 | 2009-04-01 | 重庆医科大学医药研究所 | 含10-羟基喜树碱的水溶性衍生物及制备方法 |
PA8855801A1 (es) | 2008-12-23 | 2010-07-27 | Sintesis de nucleosidos de purina | |
NZ593648A (en) * | 2008-12-23 | 2013-09-27 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
WO2010075517A2 (en) * | 2008-12-23 | 2010-07-01 | Pharmasset, Inc. | Nucleoside analogs |
EP2401281A4 (de) | 2009-02-25 | 2012-08-15 | Msd Kk | Pyrimidinpyrimidoindazolderivat |
US8481503B2 (en) | 2009-03-06 | 2013-07-09 | Merck Sharp & Dohme Corp. | Combination cancer therapy with an AKT inhibitor and other anticancer agents |
JP4750868B2 (ja) | 2009-03-19 | 2011-08-17 | 株式会社日立製作所 | 高温下で使用されるボルトの余寿命診断方法 |
PT3351558T (pt) | 2009-11-13 | 2020-04-09 | Daiichi Sankyo Europe Gmbh | Material e métodos para tratamento ou prevenção de doenças associadas a her-3 |
US8546573B2 (en) | 2009-11-18 | 2013-10-01 | Cadila Healthcare Limited | Process for the preparation of 7-ethyl-10-[4-(1-piperidino)-1-piperdino] carbonyloxy-camptothecin hydrochloride trihydrate |
AU2010321882B2 (en) * | 2009-11-18 | 2016-01-14 | Nektar Therapeutics | Salt form of a multi-arm polymer-drug conjugate |
ES2575160T3 (es) | 2010-03-15 | 2016-06-24 | The Board Of Trustees Of The University Of Illinois | Inhibidores de las interacciones que unen la subunidad alfa de la beta integrina-proteína G |
ES2551944T3 (es) | 2010-03-31 | 2015-11-24 | Gilead Pharmasset Llc | (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihidropirimidin-1-(2H)-il)-4-fluoro-3-hidroxi-4-metiltetrahidrofuran-2-il)metoxi)(fenoxi)fosforil)amino)propanoato de isopropilo cristalino |
US8530444B2 (en) * | 2010-06-01 | 2013-09-10 | Aposense Ltd. | Pharmaceutical compounds |
JP2013540694A (ja) | 2010-08-06 | 2013-11-07 | ウー3・フアルマ・ゲー・エム・ベー・ハー | Her3結合剤の前立腺治療における使用 |
US9029502B2 (en) | 2010-12-20 | 2015-05-12 | The Regents Of The University Of Michigan | Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction |
JO3283B1 (ar) | 2011-04-26 | 2018-09-16 | Sanofi Sa | تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI) |
WO2013093931A2 (en) | 2011-09-19 | 2013-06-27 | Sun Pharma Advanced Research Company Ltd. | Novel prodrugs of phenolic drugs |
AU2012319239B2 (en) | 2011-10-03 | 2017-04-20 | Mx Adjuvac Ab | Nanoparticles, process for preparation and use thereof as carrier for amphipatic of hydrophobic molecules in fields of medicine including cancer treatment and food related compounds |
US9717724B2 (en) | 2012-06-13 | 2017-08-01 | Ipsen Biopharm Ltd. | Methods for treating pancreatic cancer using combination therapies |
AU2013202947B2 (en) | 2012-06-13 | 2016-06-02 | Ipsen Biopharm Ltd. | Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan |
WO2014070233A1 (en) | 2012-10-29 | 2014-05-08 | Boston Medical Center Corporation | Brca1 mutations as predictive markers for topoisomerase i inhibitors |
CN103848840A (zh) * | 2012-12-03 | 2014-06-11 | 中国人民解放军军事医学科学院毒物药物研究所 | 喜树碱衍生物及其医药用途 |
CN103864810A (zh) * | 2012-12-07 | 2014-06-18 | 天津科技大学 | 一种新颖的10-羟基喜树碱10位衍生物制备方法及其在抗肿瘤药物中的应用 |
KR101847252B1 (ko) | 2013-03-27 | 2018-04-09 | 다이호야쿠힌고교 가부시키가이샤 | 이리노테칸염산염 수화물을 함유하는 항종양제 |
RU2668125C2 (ru) | 2013-03-27 | 2018-09-26 | Тайхо Фармасьютикал Ко., Лтд. | Противоопухолевое лекарственное средство, включающее низкодозированный гидрохлорида иринотекана гидрат |
US9907846B2 (en) | 2013-04-01 | 2018-03-06 | Mx Adjuvac Ab | Nanoparticles, composed of sterol and saponin from Quillaja saponaria Molina for use in pharmaceutical compositions |
EP2881396A1 (de) * | 2013-12-03 | 2015-06-10 | Synbias Pharma AG | Verfahren zur Synthese von Irinotecan |
US10143657B2 (en) * | 2014-01-17 | 2018-12-04 | Oncoral Pharma Aps | Solid oral dosage form of irinotecan for the treatment of cancer |
PL3170005T3 (pl) | 2014-07-18 | 2019-10-31 | Sanofi Sa | Sposób przewidywania wyniku leczenia afliberceptem u pacjenta podejrzewanego o chorobę nowotworową |
EP3250609A4 (de) | 2015-01-26 | 2018-07-11 | The University of Chicago | Il13ra-alpha-2-bindende wirkstoffe und verwendung davon bei der krebsbehandlung |
EP3250611B1 (de) | 2015-01-26 | 2021-04-21 | The University of Chicago | Car-t-zellen zur erkennung krebsspezifischer il 13r-alpha2 |
US11318131B2 (en) | 2015-05-18 | 2022-05-03 | Ipsen Biopharm Ltd. | Nanoliposomal irinotecan for use in treating small cell lung cancer |
WO2016203352A2 (en) * | 2015-06-14 | 2016-12-22 | Mohan M Alapati | Compositions and methods for the treatment of cancer |
WO2016203337A2 (en) * | 2015-06-14 | 2016-12-22 | Mohan M Alapati | Compositions and methods for the treatment of cancer |
KR102293907B1 (ko) | 2015-06-30 | 2021-08-26 | 한미약품 주식회사 | 이리노테칸 함유 경구용 고형제제 및 그 제조방법 |
PT3337467T (pt) | 2015-08-20 | 2021-01-25 | Ipsen Biopharm Ltd | Terapia de combinação utilizando irinotecano lipossomal e um inibidor parp para tratamento do cancro |
WO2017034957A1 (en) | 2015-08-21 | 2017-03-02 | Merrimack Pharmaceuticals, Inc. | Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin |
JP6877049B2 (ja) | 2015-09-25 | 2021-05-26 | ゼットワイ セラピューティクス インク.Zy Therapeutics Inc. | 多糖類−ビタミン共役体を含む粒状物に基づく薬物製剤 |
AU2016340153B2 (en) | 2015-10-16 | 2022-06-02 | Ipsen Biopharm Ltd. | Stabilizing camptothecin pharmaceutical compositions |
US9980953B2 (en) * | 2016-09-26 | 2018-05-29 | Chong Kun Dang Pharmaceutical Corp. | Combined composition for preventing or treating cancer comprising a benzophenone thiazole derivatives as a VDA and topoisomerase inhibitor |
WO2018083470A1 (en) | 2016-11-02 | 2018-05-11 | Ipsen Biopharm Ltd. | Treating gastric cancer using combination therapies comprising liposomal irinotecan, oxaliplatin, 5-fluoruracil (and leucovorin) |
CN108570057A (zh) * | 2017-03-13 | 2018-09-25 | 烟台药物研究所 | 一种合成7-乙基-10-羟基喜树碱的方法 |
TW201912173A (zh) | 2017-08-07 | 2019-04-01 | 美商安進公司 | 三陰性乳癌或結腸直腸癌伴隨肝轉移之治療 |
TW202003553A (zh) | 2018-03-15 | 2020-01-16 | 美商艾伯維有限公司 | 用於治療癌症之abbv-621與抗癌劑之組合 |
WO2019178433A1 (en) | 2018-03-15 | 2019-09-19 | Abbvie Inc. | Abbv-621 in combination with anti-cancer agents for the treatment of pancreatic cancer |
EP3669890A1 (de) | 2018-12-18 | 2020-06-24 | Croda International PLC | Filamentöse nanopartikel mit impfstoffadjuvanswirkung |
KR20210154158A (ko) | 2019-03-20 | 2021-12-20 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 클라우딘-6 항체 및 약물 컨쥬게이트 |
WO2020191344A1 (en) | 2019-03-20 | 2020-09-24 | The Regents Of The University Of California | Claudin-6 bispecific antibodies |
WO2020210376A1 (en) | 2019-04-09 | 2020-10-15 | The Board Of Trustees Of The University Of Illinois | Drug adsorbed highly porous activated carbon for enhanced drug delivery |
WO2020222668A1 (en) | 2019-04-30 | 2020-11-05 | Instituto de Medicina Molecular João Lobo Antunes | Rank pathway inhibitors in combination with cdk inhibitors |
WO2020263793A1 (en) | 2019-06-24 | 2020-12-30 | Amgen Inc. | Inhibition of sirp-gamma for cancer treatment |
CN111171077A (zh) * | 2020-01-19 | 2020-05-19 | 上海交通大学医学院附属仁济医院 | 喜树碱衍生物及其制备方法和应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3894029A (en) * | 1971-08-26 | 1975-07-08 | Basf Ag | Production of camptothecin and camptothecin-like compounds |
JPS5198300A (en) * | 1975-02-20 | 1976-08-30 | Kanputoteshin oyobi sonoruijitaino seizoho | |
US4399282A (en) * | 1979-07-10 | 1983-08-16 | Kabushiki Kaisha Yakult Honsha | Camptothecin derivatives |
US4399276A (en) * | 1981-01-09 | 1983-08-16 | Kabushiki Kaisha Yakult Honsha | 7-Substituted camptothecin derivatives |
JPS5839685A (ja) * | 1981-09-04 | 1983-03-08 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体及びその製造法 |
US4473692A (en) * | 1981-09-04 | 1984-09-25 | Kabushiki Kaisha Yakult Honsha | Camptothecin derivatives and process for preparing same |
JPS58154583A (ja) * | 1982-03-10 | 1983-09-14 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体 |
JPS58154584A (ja) * | 1982-03-10 | 1983-09-14 | Yakult Honsha Co Ltd | 5位ヒドロキシ置換カンプトテシン誘導体の製造法 |
JPS58154582A (ja) * | 1982-03-10 | 1983-09-14 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体およびその製造法 |
JPS5951289A (ja) * | 1982-09-17 | 1984-03-24 | Yakult Honsha Co Ltd | 新規な9−置換−カンプトテシン誘導体 |
-
1983
- 1983-07-14 JP JP58126946A patent/JPS6019790A/ja active Granted
-
1984
- 1984-07-05 US US06/627,980 patent/US4604463A/en not_active Expired - Lifetime
- 1984-07-05 CA CA000458228A patent/CA1235415A/en not_active Expired
- 1984-07-13 DE DE8484108257T patent/DE3470744D1/de not_active Expired
- 1984-07-13 DE DE198484108257T patent/DE137145T1/de active Pending
- 1984-07-13 AT AT84108257T patent/ATE33839T1/de active
- 1984-07-13 EP EP84108257A patent/EP0137145B1/de not_active Expired
-
1997
- 1997-06-04 LU LU90074C patent/LU90074I2/fr unknown
-
1998
- 1998-09-17 NL NL980026C patent/NL980026I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
EP0137145A1 (de) | 1985-04-17 |
US4604463A (en) | 1986-08-05 |
LU90074I2 (fr) | 1997-08-21 |
ATE33839T1 (de) | 1988-05-15 |
NL980026I2 (nl) | 1999-02-01 |
CA1235415A (en) | 1988-04-19 |
JPS6019790A (ja) | 1985-01-31 |
NL980026I1 (nl) | 1998-11-02 |
JPH034077B2 (de) | 1991-01-22 |
DE137145T1 (de) | 1985-11-21 |
EP0137145B1 (de) | 1988-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3470744D1 (en) | New camptothecin derivatives and process for preparing same | |
ATE89559T1 (de) | Camptothecin-derivate und verfahren zu ihrer herstellung. | |
EP0163599A3 (en) | Pyrimidopyrimidine derivatives, processes for producing them, pharmaceutical compositions containing them and their use as anti-allergic agents | |
KR950014097A (ko) | 피페라진 유도체 | |
UA11100A (uk) | Спосіб одержаhhя феhілалкіламіhів або їх фармакологічhо прийhятhих солей | |
DE3473763D1 (en) | Novel 4'-demethyl-4-epipodophyllotoxin derivatives, a process for their preparation and their use as medicaments | |
SE8405188D0 (sv) | Platina komplex | |
ES8105710A1 (es) | Procedimiento para preparar derivados de indolizina | |
ES8706713A1 (es) | Un procedimiento para preparar derivados de 4'-desmetil-4-epipodofilotoxina | |
ZA826755B (en) | Substituted phenylsulfonylurea derivatives,a process for their preparation and their use as herbicides,and new intermediate products for their preparation | |
AU547792B2 (en) | Pyrimido(5,4-d)pyrimidines | |
CH614448A5 (en) | Process for the preparation of novel tertiary amines and their acid addition salts, and compounds thus prepared | |
ATE31414T1 (de) | 8-substituierte pyrrolizidin-derivate und deren verwendung. | |
IE822330L (en) | 2,2-disubstituted-ethylamines | |
DE3372095D1 (en) | Novel phenylpiperazine derivatives and process for producing the same | |
HUT58270A (en) | Process for producing amine derivatives and pharmaceutical compositions containing them | |
ATE148128T1 (de) | Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung | |
ATE58532T1 (de) | (2-amino-4-aryl-thiazol-5-yl)aethanol, und deren derivate mit diuretischer aktivitaet und verfahren zu deren herstellung. | |
GB1363415A (en) | Bis-pyridyl amine compounds | |
GB1507414A (en) | Hydantoin derivatives | |
KR920700215A (ko) | 비스(1,2-디아릴-1,2-에틸렌디티오레이토)니켈-기재 착물의 제조방법 | |
SE7413858L (de) | ||
ES8305703A1 (es) | Un derivado de 2-benzoilamino-bencilamina. | |
ES488388A1 (es) | Procedimiento de preparacion de derivados hidroxilados del tiazol | |
GB1456525A (en) | Process for the manufacture of alkanolamine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
V448 | Application of spc |
Free format text: PRODUCT NAME: IRINOTECAN-HYDROCHLORID-TRIHYDRAT; REGISTRATION NO/DATE: 43289.00.00, 43290.00.00; 19980806 Spc suppl protection certif: 199 75 010 Filing date: 19990202 |
|
V457 | Spc granted |
Free format text: PRODUCT NAME: IRINOTECAN-HYDROCHLORID-TRIHYDRAT; REGISTRATION NO/DATE: 43289.00.00, 43290.00.00; 19980806 Spc suppl protection certif: 199 75 010 Filing date: 19990202 |
|
V464 | Spc expired |
Free format text: PRODUCT NAME: IRINOTECAN-HYDROCHLORID-TRIHYDRAT; REGISTRATION NO/DATE: 43289.00.00, 43290.00.00; 19980806 Spc suppl protection certif: 199 75 010 Filing date: 19990202 |
|
R081 | Change of applicant/patentee |
Owner name: KABUSHIKI KAISHA YAKULT HONSHA, JP Free format text: FORMER OWNER: KABUSHIKI KAISHA YAKULT HONSHA, TOKIO/TOKYO, JP Spc suppl protection certif: 19975010 Filing date: 19990202 Expiry date: 20040714 Extension date: 20090713 Owner name: KABUSHIKI KAISHA YAKULT HONSHA, 1-19, HIGASHIS, JP Free format text: FORMER OWNER: KABUSHIKI KAISHA YAKULT HONSHA, TOKIO/TOKYO, JP Spc suppl protection certif: 19975010 Filing date: 19990202 Expiry date: 20040714 Extension date: 20090713 |
|
R082 | Change of representative |
Free format text: PRODUCT NAME: IRINOTECAN-HYDROCHLORID-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 43289.00.00 43290.00.00 19980806 FIRST REGISTRATION: FRANKREICH 558 822.2 558 823.9 558 824.5 558 825.1 19950505 Spc suppl protection certif: 19975010 Filing date: 19990202 Expiry date: 20040714 Representative=s name: VOSSIUS & PARTNER, DE Extension date: 20090713 Free format text: PRODUCT NAME: IRINOTECAN-HYDROCHLORID-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 43289.00.00 43290.00.00 19980806 FIRST REGISTRATION: FRANKREICH 558 822.2 558 823.9 558 824.5 558 825.1 19950505 Spc suppl protection certif: 19975010 Filing date: 19990202 Expiry date: 20040714 Representative=s name: VOSSIUS & PARTNER PATENTANWAELTE RECHTSANWAELT, DE Extension date: 20090713 |